{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:36:25Z","timestamp":1776893785177,"version":"3.51.2"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T00:00:00Z","timestamp":1324425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold>Functional dyspepsia (FD) is a common condition seen in primary gastroenterology practice. The present study was conducted to compare the clinical effectiveness of mosapride and teprenone in patients with FD.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Prospective clinical comparative study with random allocation of open labeled medications was performed as a multicenter trial in Japan. 1042 patients presenting symptoms of FD, either with gastric stasis (GSS) and\/or epigastric pain (EPS), were enrolled. After initial endoscopic evaluation, medication either with mosapride 5\u2003mg tid or teprenone 50\u2003mg tid was started. Severity and frequency of GSS and EPS, health\u2010related quality of life (HR\u2010QOL) by the SF\u201036 Japanese version, and patients' compliance to medication was evaluated.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Organic lesions were found in 90 patients (9%) in the 1027 patients examined by endoscopy. Among those without any specific lesions detected by endoscopy, gastrointestinal symptoms were resolved within one week after the endoscopy in 264 (28%) patients before initiating medication. 618 patients who remained symptomatic were randomized to medication either with mosapride (<jats:italic>n<\/jats:italic>\u2003=\u2003311) or teprenone (<jats:italic>n<\/jats:italic>\u2003=\u2003307). Two\u2010week treatment with mosapride significantly improved GSS and EPS, while teprenone tended to improve only GSS. Mosapride also improved HR\u2010QOL. 91% of patients treated with mosapride favored their medication, while only 52% of patients treated with teprenone favored their medication.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>Endoscopic evaluation at patients' presentation was effective to find active lesions and to improve FD symptoms. Mosapride was more favorably accepted than teprenone by the patients with sufficient safety and efficacy.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2011.06949.x","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T16:08:36Z","timestamp":1318867716000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Large\u2010scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega\u2010Study (JMMS)"],"prefix":"10.1111","volume":"27","author":[{"given":"Michio","family":"Hongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Harasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Matsueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyasu","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Hanyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70542-6"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii37"},{"key":"e_1_2_6_5_2","first-page":"368","article-title":"[Functional dyspepsia.]","volume":"126","author":"Hongo M","year":"2001","journal-title":"Jap. Med. Assoc. J."},{"key":"e_1_2_6_6_2","first-page":"3842","article-title":"[Diagnosis of functional dyspepsia (NUD).]","volume":"107","author":"Hongo M","year":"1997","journal-title":"Jap. Med. Assoc. J."},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198904000-00011"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02474.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00106a023"},{"key":"e_1_2_6_11_2","first-page":"51","article-title":"AS\u20104370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties","volume":"300","author":"Yoshida N","year":"1989","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"2","key":"e_1_2_6_12_2","first-page":"A671","article-title":"Inhibitory effect of mosapride citrate, a 5\u2010HT4 receptor agonist, on gastric distension\u2010induced visceral pain behavior and abdominal striated muscle contraction in conscious rats","volume":"128","author":"Seto Y","year":"2005","journal-title":"Gastroenterology"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00095-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(98)70243-3"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-6-865"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116483"},{"key":"e_1_2_6_17_2","first-page":"40","article-title":"[The medical care guidelines for FD.]","volume":"26","author":"Hasebe T","year":"1999","journal-title":"Clinica"},{"key":"e_1_2_6_18_2","first-page":"1973","article-title":"[A study of the clinical epidemiology of non\u2010ulcer dyspepsia (NUD).]","volume":"89","author":"Kiyota K","year":"1992","journal-title":"J Japan Soc Gastro"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01646.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018803129779"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3565(25)24782-6","article-title":"AS\u20104370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs","volume":"257","author":"Yoshida N","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_22_2","first-page":"25","article-title":"Therapeutic effect of Ea\u20100671 on acute gastritis and acute exacerbation in chronic gastritis. Multicenter double\u2010blind controlled study compared with cetraxate, mainly using endoscopic evaluation","volume":"16","author":"Oshiba S","year":"1988","journal-title":"Clin. Eval. (Rinsho Hyoka)"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199296"},{"key":"e_1_2_6_24_2","first-page":"660","article-title":"Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials","volume":"91","author":"Veldhuyzen van Zanten SJ","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01236.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40122.x"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2011.06949.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2011.06949.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T23:54:44Z","timestamp":1741823684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2011.06949.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1440-1746.2011.06949.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06949.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,21]]},"assertion":[{"value":"2011-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}